I missed the dial-in too. They usually appear to wrap things up as soon as possible , answering as few questions as possible.Any difference this year?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025